Organic sulfone compounds,exhibiting interesting bioactivities,were widely applied in the field of pharmaceutical and medicine.And numerous of sulfuryl group-involved drugs were approved by the Food and Drug Administr...Organic sulfone compounds,exhibiting interesting bioactivities,were widely applied in the field of pharmaceutical and medicine.And numerous of sulfuryl group-involved drugs were approved by the Food and Drug Administration(FDA).Odevixibat,maralixibat chloride and belzutifan approved in 2021 could be applied in the treatment of progressive familial intrahepatic cholestasis(PFIC),cholestatic pruritus and clear cell renal cell carcinoma(ccRCC),respectively.In 2022,abrocitinib,pyrukynd and voquezna were approved for the treatment of atopic dermatitis,pyruvate kinase deficiency(PKD)and acid-related disorders,respectively.Defencath for preventing bloodstream infections,sparsentan for treatment of proteinuria related to IgA nephropathy,and xacduro for treatment of hospital-acquired bacterial pneumonia(HABP)were approved in 2023.In this review,the synthesis and therapies of these sulfuryl group-involved drugs approved from 2021 to 2023 are discussed in details.展开更多
利用Weaver海浪模型,对拖曳式Overhauser海洋磁场传感器海浪磁噪声与深度、波幅等之间的关系进行了理论分析,证明了在极端海况条件下对海浪磁噪声进行抑制的必要性.为提高海洋磁测灵敏度,提出了一种基于改进的Sage-Husa自适应Kalman算...利用Weaver海浪模型,对拖曳式Overhauser海洋磁场传感器海浪磁噪声与深度、波幅等之间的关系进行了理论分析,证明了在极端海况条件下对海浪磁噪声进行抑制的必要性.为提高海洋磁测灵敏度,提出了一种基于改进的Sage-Husa自适应Kalman算法的海浪磁场噪声抑制方法.仿真结果表明,该方法能在不需要先验的噪声统计或实时参考噪声的情况下,实现磁场噪声协方差的快速收敛;且与常规的Sage-Husa算法相比,改进后的Sage-Husa算法降低了对初始参数的依赖性.另外,设计了一种拖曳式Overhauser海洋磁场传感器测试仪来测试上述算法.对比结果表明该方法不仅实现了磁场噪声统计参数的自适应估计,而且比经典Kalman滤波具有更好的滤波效果;此外,海浪磁噪声的功率谱密度由50 p T/Hz1/2@1Hz下降到6 p T/Hz1/2@1Hz.展开更多
文摘Organic sulfone compounds,exhibiting interesting bioactivities,were widely applied in the field of pharmaceutical and medicine.And numerous of sulfuryl group-involved drugs were approved by the Food and Drug Administration(FDA).Odevixibat,maralixibat chloride and belzutifan approved in 2021 could be applied in the treatment of progressive familial intrahepatic cholestasis(PFIC),cholestatic pruritus and clear cell renal cell carcinoma(ccRCC),respectively.In 2022,abrocitinib,pyrukynd and voquezna were approved for the treatment of atopic dermatitis,pyruvate kinase deficiency(PKD)and acid-related disorders,respectively.Defencath for preventing bloodstream infections,sparsentan for treatment of proteinuria related to IgA nephropathy,and xacduro for treatment of hospital-acquired bacterial pneumonia(HABP)were approved in 2023.In this review,the synthesis and therapies of these sulfuryl group-involved drugs approved from 2021 to 2023 are discussed in details.
文摘利用Weaver海浪模型,对拖曳式Overhauser海洋磁场传感器海浪磁噪声与深度、波幅等之间的关系进行了理论分析,证明了在极端海况条件下对海浪磁噪声进行抑制的必要性.为提高海洋磁测灵敏度,提出了一种基于改进的Sage-Husa自适应Kalman算法的海浪磁场噪声抑制方法.仿真结果表明,该方法能在不需要先验的噪声统计或实时参考噪声的情况下,实现磁场噪声协方差的快速收敛;且与常规的Sage-Husa算法相比,改进后的Sage-Husa算法降低了对初始参数的依赖性.另外,设计了一种拖曳式Overhauser海洋磁场传感器测试仪来测试上述算法.对比结果表明该方法不仅实现了磁场噪声统计参数的自适应估计,而且比经典Kalman滤波具有更好的滤波效果;此外,海浪磁噪声的功率谱密度由50 p T/Hz1/2@1Hz下降到6 p T/Hz1/2@1Hz.